Steris PLC (STE) Holdings Reduced by Fmr LLC

Fmr LLC reduced its holdings in Steris PLC (NYSE:STE) by 17.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,601,608 shares of the medical equipment provider’s stock after selling 563,195 shares during the period. Fmr LLC owned approximately 3.08% of Steris worth $273,195,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. ARP Americas LP acquired a new stake in shares of Steris during the 2nd quarter worth approximately $212,000. Empirical Finance LLC acquired a new stake in shares of Steris during the 2nd quarter worth approximately $216,000. Ausdal Financial Partners Inc. acquired a new stake in shares of Steris during the 2nd quarter worth approximately $218,000. Intrust Bank NA acquired a new stake in shares of Steris during the 2nd quarter worth approximately $234,000. Finally, Meeder Asset Management Inc. grew its holdings in shares of Steris by 739.8% during the 2nd quarter. Meeder Asset Management Inc. now owns 2,343 shares of the medical equipment provider’s stock worth $246,000 after purchasing an additional 2,064 shares in the last quarter. 88.76% of the stock is currently owned by institutional investors.

Shares of STE stock opened at $107.83 on Wednesday. The company has a current ratio of 2.65, a quick ratio of 2.02 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $8.95 billion, a P/E ratio of 25.98 and a beta of 1.06. Steris PLC has a one year low of $82.88 and a one year high of $117.48.



Steris (NYSE:STE) last announced its quarterly earnings results on Wednesday, August 8th. The medical equipment provider reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.01. The business had revenue of $638.76 million for the quarter, compared to analyst estimates of $638.63 million. Steris had a return on equity of 11.80% and a net margin of 11.42%. Steris’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.85 EPS. Research analysts expect that Steris PLC will post 4.71 earnings per share for the current fiscal year.

Several analysts have recently weighed in on the company. KeyCorp lifted their price objective on Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 9th. Stephens reissued a “buy” rating and set a $125.00 price objective on shares of Steris in a report on Thursday, August 9th. JMP Securities lifted their price objective on Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a report on Thursday, August 9th. Finally, Zacks Investment Research raised Steris from a “sell” rating to a “hold” rating in a report on Thursday, September 20th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Steris currently has an average rating of “Buy” and an average target price of $100.86.

In related news, VP Karen L. Burton sold 1,300 shares of the business’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $114.39, for a total value of $148,707.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 2.38% of the stock is owned by insiders.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: Are analyst ratings accurate?

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply